In domestic companies, sales of products from multinational pharmaceutical companies accounted for more than 30% of total sales

Domestic pharmaceutical companies are selling the products of multinational pharmaceutical companies to overcome decrease in sales due to overall drug price cut carried out in April 2012. Now in domestic companies, sales of products from multinational pharmaceutical companies accounts for now more than 30% of total sales.

Considering company-specific product sales, that in Yuhan corporation ac...